The A20 leukemia transplantable cell line was chosen as the tumor model because PD-1 and PD-L2 cell surface receptors are completely absent and the expression of CD80 is barely detectable, whereas PD-L1 is clearly expressed (Figure 1A). Here, CD80 is linked to leukemia.